Dec 12, 2025 10:47AM
Nov 5, 2025 07:00AM
Jul 30, 2025 07:00AM
May 20, 2025 05:21PM
May 19, 2025 04:52AM
May 20, 2024 08:25PM
May 8, 2024 07:00AM Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
Feb 25, 2024 08:36PM
Feb 23, 2024 08:15PM
Feb 12, 2024 11:21AM
Feb 9, 2024 08:00PM
Jan 31, 2024 07:00AM
Nov 8, 2023 07:00AM
Aug 21, 2023 04:00PM Teva Pharma (TEVA) Settles Price Fixing Charges With DOJ
Aug 21, 2023 04:00PM
Aug 2, 2023 07:00AM
Jul 27, 2023 08:00AM
Jul 24, 2023 06:03AM
Jun 12, 2023 07:00AM
Jun 12, 2023 05:19AM
May 18, 2023 08:30AM Teva Launches New “Pivot to Growth” Strategy
May 18, 2023 07:55AM
May 15, 2023 08:04AM
May 15, 2023 08:00AM
May 10, 2023 07:00AM
May 1, 2023 05:25AM
Apr 28, 2023 08:22PM
Apr 28, 2023 07:22PM Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophren
Mar 1, 2023 04:11PM
Feb 27, 2023 03:30AM
Feb 8, 2023 07:00AM
Jan 9, 2023 08:02AM
Jan 9, 2023 08:00AM
Jan 6, 2023 07:03AM
Jan 6, 2023 07:00AM Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
Jan 6, 2023 04:00AM
Dec 22, 2022 04:00AM
Nov 22, 2022 08:31AM
Nov 22, 2022 08:30AM
Nov 3, 2022 07:00AM
Oct 20, 2022 06:50AM
Oct 7, 2022 08:37AM Teva Pharma (TEVA) Reaches Agreement With Arkansas to Settle the State’s Price Fixing Claims
Oct 7, 2022 08:30AM
Sep 30, 2022 08:00AM
Sep 30, 2022 08:00AM
Jul 26, 2022 04:55PM
Jul 12, 2022 10:30AM
Jul 12, 2022 10:30AM
Jun 15, 2022 04:01PM Alvotech, a Global Pureplay Biosimilars Company, to Debut on Nasdaq Under the Ticker ALVO on June 16
Jun 9, 2022 07:00AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All